Literature DB >> 19693674

A flavivirus protein M-derived peptide directly permeabilizes mitochondrial membranes, triggers cell death and reduces human tumor growth in nude mice.

Magali Brabant1, Ludwig Baux, Richard Casimir, Jean Paul Briand, Olivier Chaloin, Mathieu Porceddu, Nelly Buron, David Chauvier, Myriam Lassalle, Hervé Lecoeur, Alain Langonné, Sylvie Dupont, Olivier Déas, Catherine Brenner, Dominique Rebouillat, Sylviane Muller, Annie Borgne-Sanchez, Etienne Jacotot.   

Abstract

Dengue viruses belong to the Flavivirus family and are responsible for hemorrhagic fever in Human. Dengue virus infection triggers apoptosis especially through the expression of the small membrane (M) protein. Using isolated mitochondria, we found that synthetic peptides containing the C-terminus part of the M ectodomain caused apoptosis-related mitochondrial membrane permeabilization (MMP) events. These events include matrix swelling and the dissipation of the mitochondrial transmembrane potential (DeltaPsi(m)). Protein M Flavivirus sequence alignments and helical wheel projections reveal a conserved distribution of charged residues. Moreover, when combined to the cell penetrating HIV-1 Tat peptide transduction domain (Tat-PTD), this sequence triggers a caspase-dependent cell death associated with DeltaPsi(m) loss and cytochrome c release. Mutational approaches coupled to functional screening on isolated mitochondria resulted in the selection of a protein M derived sequence containing nine residues with potent MMP-inducing properties on isolated mitochondria. A chimeric peptide composed of a Tat-PTD linked to the 9-mer entity triggers MMP and cell death. Finally, local administration of this chimeric peptide induces growth inhibition of xenograft prostate PC3 tumors in immuno-compromised mice, and significantly enhances animal survival. Together, these findings support the notion of using viral genomes as valuable sources to discover mitochondria-targeted sequences that may lead to the development of new anticancer compounds.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19693674     DOI: 10.1007/s10495-009-0394-y

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  6 in total

1.  A Single Amino Acid Substitution in the M Protein Attenuates Japanese Encephalitis Virus in Mammalian Hosts.

Authors:  Mélissanne de Wispelaere; Cécile Khou; Marie-Pascale Frenkiel; Philippe Desprès; Nathalie Pardigon
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

2.  HIV-1 Tat protein directly induces mitochondrial membrane permeabilization and inactivates cytochrome c oxidase.

Authors:  H Lecoeur; A Borgne-Sanchez; O Chaloin; R El-Khoury; M Brabant; A Langonné; M Porceddu; J-J Brière; N Buron; D Rebouillat; C Péchoux; A Deniaud; C Brenner; J-P Briand; S Muller; P Rustin; E Jacotot
Journal:  Cell Death Dis       Date:  2012-03-15       Impact factor: 8.469

3.  Dengue Virus Impairs Mitochondrial Fusion by Cleaving Mitofusins.

Authors:  Chia-Yi Yu; Jian-Jong Liang; Jin-Kun Li; Yi-Ling Lee; Bi-Lan Chang; Chan-I Su; Wei-Jheng Huang; Michael M C Lai; Yi-Ling Lin
Journal:  PLoS Pathog       Date:  2015-12-30       Impact factor: 6.823

Review 4.  Molecular Determinants of West Nile Virus Virulence and Pathogenesis in Vertebrate and Invertebrate Hosts.

Authors:  Lise Fiacre; Nonito Pagès; Emmanuel Albina; Jennifer Richardson; Sylvie Lecollinet; Gaëlle Gonzalez
Journal:  Int J Mol Sci       Date:  2020-11-30       Impact factor: 5.923

Review 5.  Flaviviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines.

Authors:  Yuhong Pan; Wenjun Cai; Anchun Cheng; Mingshu Wang; Zhongqiong Yin; Renyong Jia
Journal:  Front Immunol       Date:  2022-01-28       Impact factor: 7.561

6.  A Molecular Determinant of West Nile Virus Secretion and Morphology as a Target for Viral Attenuation.

Authors:  Justine Basset; Julien Burlaud-Gaillard; Maxence Feher; Philippe Roingeard; Félix A Rey; Nathalie Pardigon
Journal:  J Virol       Date:  2020-06-01       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.